Mackenzie Financial’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
Mackenzie Financial's HALO Position: Q2 2026 in Review
Mackenzie Financial reduced its Halozyme (HALO) stake by 76% in Q2 2026, selling an estimated $3.61M and leaving 16,327 shares worth $1.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1146.
Mackenzie Financial first reported a position in HALO in Q1 2019 and has held it in 28 quarters since. The position peaked at $6.16M in Q2 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- Mackenzie Financial held 16,327 shares of Halozyme worth $1.28M as of Q2 2026.
- Mackenzie Financial sold 52,999 Halozyme shares in Q2 2026, an estimated $3.61M.
- Halozyme made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1146 holding.
- Mackenzie Financial first reported a position in Halozyme in Q1 2019 and has held it in 28 quarters since.
- Mackenzie Financial's Halozyme position peaked at $6.16M in Q2 2025.
- 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.